EXACT Sciences Corporation Stock News

In the rapidly evolving healthcare sector, the idea of personalized medicine stocks stands out, revolutionizing patient care by tailoring treatments with their individual genetic profiles. These stock

If you're searching for digital health stocks to add to your portfolio, look no further. Technological innovation is leading to the increased digitalization and personalization of healthcare.

In a world in constant evolution and growth, more and more companies are needed that are committed to development and research in the health area. These biotech companies are not only doing the job, b

We have narrowed our search to five biotech stocks with strong potential for 2024. These are: LEGN, BGNE, GILD, EXAS, SRPT.

Multi-billionaire investor Ken Fisher wrote recently that the stocks of relatively small companies tend to be very unpopular with the Street during the early phase of bull markets. Therefore, Fisher's

From a technical perspective, Exact Sciences (EXAS) is looking like an interesting pick, as it just reached a key level of support. EXAS recently overtook the 20-day moving average, and this suggests

Exact Sciences' (EXAS) Screening revenue upside is primarily attributable to broad-based momentum in Cologuard adoption.

MADISON, Wis. , Nov. 1, 2023 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate

Many investors are probably upset that the yields of the 10-year treasury bonds are trading around 5%. It's true that higher bond yields do increases companies' borrowing costs and make stocks less at

With inflation under control, and economic growth still strong, there should be plenty of winning stocks between now and the end of the year. In fact, consider this.

At the end of September, Cathie Wood sat down with Morningstar to discuss the current and future state of Ark Invest, including the investment management firm's flagship fund, the ARK Innovation ETF (

There's no doubt that America is aging. The numbers do not lie.

Investors remain optimistic about Exact Sciences (EXAS) due to its strategic prioritization and positive solvency.

MADISON, Wis. , Oct. 9, 2023 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its thi

MADISON, Wis. , Oct. 9, 2023 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the company will present late-break